EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimony susceptible Leishmania donovani : evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era

Sushmita Ghosh, Aditya Verma, Dhiraj Kumar, Deepak Kumar Deep, V Ramesh, Poonam Salotra iD, Ruchi Singh iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.04026-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Sushmita Ghosh und 6 weiteren Autor:innen. Beteiligte Einrichtung: ICMR, National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India. Hauptthemen laut MEDLINE: Leishmania donovani, Phosphorylcholine, Leishmaniasis, Visceral, Antiprotozoal Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research (ICMR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-kala-azar dermal leishmaniasis (PKDL) patients are a key source of Leishmania donovani parasites, hindering the goal of eliminating visceral leishmaniasis (VL). Monitoring treatment response and parasite susceptibility is essential due to increasing drug resistance. We assessed the drug susceptibility of PKDL isolates ( n = 18) from pre-miltefosine (MIL) era (1997–2004) with isolates ( n = 16) from the post-miltefosine era (2010–2019) and post-miltefosine treatment relapse isolates ( n = 5) towards miltefosine and amphotericin B (AmB) at promastigote stage and towards sodium antimony gluconate (SAG) at amastigote stage. PKDL isolates were examined for mutation in gene-encoding AQP1 transporter, C26882T mutation on chromosome 24, and miltefosine-transporter (MT). PKDL isolates from the post-miltefosine era were significantly more susceptible to SAG than SAG-resistant isolates from the pre-miltefosine era ( P = 0.0002). There was no significant difference in the susceptibility of parasites to miltefosine between pre- and post-miltefosine era isolates. The susceptibility of PKDL isolates towards AmB remained unchanged between the pre- and post-miltefosine era. However, the post-miltefosine era isolates had a higher IC 50 value towards AmB compared with PKDL relapse isolates. We did not find any association between AQP1 gene sequence variation and susceptibility to SAG, or between miltefosine susceptibility and single nucleotide polymorphisms (SNPs in the MT gene. This study demonstrates that recent isolates of Leishmania have resumed susceptibility to antimonials in vitro . The study also offers significant insights into the intrinsic drug susceptibility of Leishmania parasites over the past two decades, covering the period before the introduction of miltefosine and after its extensive use. IMPORTANCE Post-kala-azar dermal leishmaniasis (PKDL) patients, a key source of Leishmania donovani parasites, hinder eliminating visceral-leishmaniasis. Assessment of the susceptibility of PKDL isolates to antimony, miltefosine (MIL), and amphotericin-B indicated that recent isolates remain susceptible to antimony, enabling its use with other drugs for treating PKDL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania donovaniPhosphorylcholineLeishmaniasis, VisceralAntiprotozoal AgentsAntimonyLeishmaniasis, CutaneousDrug ResistanceAmphotericin BHumansParasitic Sensitivity TestsAntimony Sodium GluconateMutation

Stichwörter der Autor:innen

Leishmaniaamphotericin Bantimonymiltefosinemultidrug resistancepost kala azar dermal leishmaniasis

Substanzen

miltefosinePhosphorylcholineAntiprotozoal AgentsAntimonyAmphotericin BAntimony Sodium Gluconate

Autor:innen und Institutionen

  • ICMR, National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India.
  • Department of Dermatology and STD, Safdarjung Hospital, Vardhman Mahavir Medical College, New Delhi, India.

ORCID-Profile: Poonam Salotra, Ruchi Singh

Förderung

  • Indian Council of Medical Research (ICMR)

Zitieren

APA

Ghosh, S., Verma, A., Kumar, D., Deep, D. K., Ramesh, V., Salotra, P., & Singh, R. (2024). Antimony susceptible Leishmania donovani : evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04026-23

Vancouver

Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, et al. Antimony susceptible Leishmania donovani : evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era. Microbiology Spectrum. 2024. doi:10.1128/spectrum.04026-23

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Sushmita and Verma, Aditya and Kumar, Dhiraj and Deep, Deepak Kumar and Ramesh, V and Salotra, Poonam and Singh, Ruchi},
  title = {Antimony susceptible Leishmania donovani : evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.04026-23}
}
Kostenlos starten →